SCHEMBL25614647

SCHEMBL25614647

c1cc2c(c(-c3c4ccccc4c(-c4ccc(-c5ccc6c(c5)oc5ccccc56)cc4)c4ccccc34)c1)C1(c3c-2ccc2ccccc32)C2CC3CC(C2)CC1C3

nearest known ligand 0.33

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 1/20 0.31
NPC1 O15118 2/20 0.31
RAB9A P51151 2/20 0.31
MMP12 P39900 1/20 0.31
MMP13 P45452 1/20 0.31
ATM Q13315 1/20 0.31
DUSP3 P51452 1/20 0.31
PRKDC P78527 1/20 0.31
GAA P10253 2/20 0.31
KMT2A Q03164 2/20 0.31
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
MAPT P10636 1/20 0.31
HPGD P15428 1/20 0.31
MEN1 O00255 1/20 0.30
LMNA P02545 1/20 0.30
HTT P42858 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25614612 0.90 HCRTR1 (0.30) HCRTR1NPC1RAB9AMMP12MMP13
SCHEMBL25618434 0.90
SCHEMBL25614637 0.90 HCRTR1 (0.30) HCRTR1KMT2AKDM4EALDH1A1MAPT
SCHEMBL25614834 0.88
SCHEMBL25614592 0.87 DUSP3 (0.31) DUSP3GAAKMT2AKDM4EALDH1A1
SCHEMBL24316933 0.86 DUSP3 (0.31) DUSP3PRKDCGAAKMT2AKDM4E
SCHEMBL25614621 0.86 KDM4E (0.32) DUSP3GAAKMT2AKDM4EALDH1A1
SCHEMBL25614803 0.85
SCHEMBL25618473 0.85 HSD11B1 (0.35) RAB9AKMT2AALDH1A1MAPTMEN1
SCHEMBL25614651 0.84 TDP1 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11800792-B2 Organic compound with spirocyclic adamantane, and electronic element and electronic device using same SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-24 US disclosed
US-11800792-B2 Organic compound with spirocyclic adamantane, and electronic element and electronic device using same SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-24 US disclosed
US-20230200215-A1 ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-06-22 US disclosed
US-20230200215-A1 ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11800792-B2 Organic compound with spirocyclic adamantane, and electronic element and electronic device using same OR51E2, SQLE, ODC1 HCRTR1 2317/4885NPC1 1101/4885RAB9A 1198/4885
US-20230200215-A1 ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME LEF1, OCIAD1, OR10J3 HCRTR1 4032/4885NPC1 2204/4885RAB9A 2496/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.